HEADER TRANSFERASE/INHIBITOR 07-SEP-14 4WD5 TITLE CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH QL-X138 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPIDERMAL GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 694-1022; COMPND 5 SYNONYM: PROTO-ONCOGENE C-ERBB-1,RECEPTOR TYROSINE-PROTEIN KINASE COMPND 6 ERBB-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EGFR, ERBB, ERBB1, HER1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF9 KEYWDS EGFR, T790M, GATEKEEPER MUTATION, INHIBITOR, TRANSFERASE-INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.H.YUN,M.J.ECK REVDAT 2 27-SEP-23 4WD5 1 REMARK REVDAT 1 04-MAY-16 4WD5 0 JRNL AUTH H.WU,C.HU,A.WANG,E.E.WEISBERG,Y.CHEN,C.H.YUN,W.WANG,X.LIU, JRNL AUTH 2 B.TIAN,J.WANG,Z.ZHAO,Y.LIANG,B.LI,L.WANG,B.WANG,C.CHEN, JRNL AUTH 3 S.J.BUHRLAGE,S.M.FERNADNERS,J.GRIFFIN,J.R.BROWN,M.J.ECK, JRNL AUTH 4 J.LIU,Q.LIU,N.S.GRAY JRNL TITL CRYSTAL STRUCTURE OF EGFR 696-1022 T790M IN COMPLEX WITH JRNL TITL 2 QL-X138 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.64 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 12043 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 592 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.6461 - 5.1045 1.00 3107 141 0.2007 0.2318 REMARK 3 2 5.1045 - 4.0531 1.00 2933 149 0.1957 0.2202 REMARK 3 3 4.0531 - 3.5412 1.00 2914 161 0.2193 0.2405 REMARK 3 4 3.5412 - 3.2176 0.88 2497 141 0.2670 0.3108 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.980 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 4886 REMARK 3 ANGLE : 1.376 6619 REMARK 3 CHIRALITY : 0.082 750 REMARK 3 PLANARITY : 0.016 827 REMARK 3 DIHEDRAL : 23.604 1820 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4WD5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000203602. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.008 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12127 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 10.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3IKA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES (PH 7.5), 21% PEG6000, 0.3 REMARK 280 M NACL, AND 5 MM TRIS(2-CARBOXYETHYL)- PHOSPHINE (TCEP), VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.78750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.93000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.64400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.93000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.78750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.64400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 692 REMARK 465 SER A 693 REMARK 465 HIS A 988 REMARK 465 LEU A 989 REMARK 465 PRO A 990 REMARK 465 SER A 991 REMARK 465 PRO A 992 REMARK 465 THR A 993 REMARK 465 ASP A 994 REMARK 465 SER A 995 REMARK 465 ASN A 996 REMARK 465 PHE A 997 REMARK 465 TYR A 998 REMARK 465 ARG A 999 REMARK 465 ALA A 1000 REMARK 465 LEU A 1001 REMARK 465 MET A 1002 REMARK 465 ASP A 1003 REMARK 465 GLU A 1004 REMARK 465 GLU A 1005 REMARK 465 ASP A 1006 REMARK 465 MET A 1007 REMARK 465 ASP A 1008 REMARK 465 GLY A 1022 REMARK 465 GLY B 692 REMARK 465 SER B 693 REMARK 465 PRO B 694 REMARK 465 SER B 695 REMARK 465 GLY B 696 REMARK 465 LEU B 862 REMARK 465 GLY B 863 REMARK 465 ALA B 864 REMARK 465 GLU B 865 REMARK 465 GLU B 868 REMARK 465 HIS B 988 REMARK 465 LEU B 989 REMARK 465 PRO B 990 REMARK 465 SER B 991 REMARK 465 PRO B 992 REMARK 465 ASP B 1003 REMARK 465 GLU B 1004 REMARK 465 GLU B 1005 REMARK 465 ASP B 1006 REMARK 465 MET B 1007 REMARK 465 ASP B 1008 REMARK 465 LEU B 1017 REMARK 465 ILE B 1018 REMARK 465 PRO B 1019 REMARK 465 GLN B 1020 REMARK 465 GLN B 1021 REMARK 465 GLY B 1022 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PRO A 694 CG CD REMARK 470 LYS A 708 CE NZ REMARK 470 GLU A 709 OE1 OE2 REMARK 470 LYS A 713 CE NZ REMARK 470 PHE A 723 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 728 CE NZ REMARK 470 ARG A 748 CD NE CZ NH1 NH2 REMARK 470 GLU A 865 CG CD OE1 OE2 REMARK 470 GLU A 872 CG CD OE1 OE2 REMARK 470 GLU A 884 OE1 OE2 REMARK 470 ARG A 962 NE CZ NH1 NH2 REMARK 470 GLU A 963 CD OE1 OE2 REMARK 470 ARG A 973 CG CD NE CZ NH1 NH2 REMARK 470 VAL A1011 CG1 CG2 REMARK 470 ASP A1012 CG OD1 OD2 REMARK 470 ASP A1014 OD1 OD2 REMARK 470 TYR A1016 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE A1018 CG1 CG2 CD1 REMARK 470 GLN A1020 CG CD OE1 NE2 REMARK 470 GLN A1021 CG CD OE1 NE2 REMARK 470 GLU B 697 CG CD OE1 OE2 REMARK 470 GLU B 734 CG CD OE1 OE2 REMARK 470 GLU B 736 CG CD OE1 OE2 REMARK 470 LYS B 739 CG CD CE NZ REMARK 470 GLU B 804 CG CD OE1 OE2 REMARK 470 GLU B 866 CG CD OE1 OE2 REMARK 470 LYS B 867 CG CD CE NZ REMARK 470 TYR B 869 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 872 CG CD OE1 OE2 REMARK 470 GLU B 922 CG CD OE1 OE2 REMARK 470 GLU B 928 CD OE1 OE2 REMARK 470 GLU B 931 CG CD OE1 OE2 REMARK 470 LYS B 960 CG CD CE NZ REMARK 470 PHE B 997 CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 999 CG CD NE CZ NH1 NH2 REMARK 470 LEU B1001 CG CD1 CD2 REMARK 470 VAL B1010 CG1 CG2 REMARK 470 TYR B1016 CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 852 OE2 GLU A 1015 1.53 REMARK 500 OD1 ASP A 837 ND2 ASN A 842 1.86 REMARK 500 OD1 ASP B 837 ND2 ASN B 842 1.93 REMARK 500 CD1 ILE A 946 OE1 GLU A 967 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 934 C - N - CD ANGL. DEV. = -14.3 DEGREES REMARK 500 PRO A 975 C - N - CD ANGL. DEV. = -13.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3LH A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 1101 DBREF 4WD5 A 694 1022 UNP P00533 EGFR_HUMAN 694 1022 DBREF 4WD5 B 694 1022 UNP P00533 EGFR_HUMAN 694 1022 SEQADV 4WD5 GLY A 692 UNP P00533 EXPRESSION TAG SEQADV 4WD5 SER A 693 UNP P00533 EXPRESSION TAG SEQADV 4WD5 MET A 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQADV 4WD5 GLY B 692 UNP P00533 EXPRESSION TAG SEQADV 4WD5 SER B 693 UNP P00533 EXPRESSION TAG SEQADV 4WD5 MET B 790 UNP P00533 THR 790 ENGINEERED MUTATION SEQRES 1 A 331 GLY SER PRO SER GLY GLU ALA PRO ASN GLN ALA LEU LEU SEQRES 2 A 331 ARG ILE LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL SEQRES 3 A 331 LEU GLY SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU SEQRES 4 A 331 TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA SEQRES 5 A 331 ILE LYS GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN SEQRES 6 A 331 LYS GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL SEQRES 7 A 331 ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU SEQRES 8 A 331 THR SER THR VAL GLN LEU ILE MET GLN LEU MET PRO PHE SEQRES 9 A 331 GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN SEQRES 10 A 331 ILE GLY SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE SEQRES 11 A 331 ALA LYS GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL SEQRES 12 A 331 HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR SEQRES 13 A 331 PRO GLN HIS VAL LYS ILE THR ASP PHE GLY LEU ALA LYS SEQRES 14 A 331 LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY SEQRES 15 A 331 GLY LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE SEQRES 16 A 331 LEU HIS ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER SEQRES 17 A 331 TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE GLY SER SEQRES 18 A 331 LYS PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER SEQRES 19 A 331 ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE SEQRES 20 A 331 CYS THR ILE ASP VAL TYR MET ILE MET VAL LYS CYS TRP SEQRES 21 A 331 MET ILE ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU SEQRES 22 A 331 ILE ILE GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG SEQRES 23 A 331 TYR LEU VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SEQRES 24 A 331 SER PRO THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP SEQRES 25 A 331 GLU GLU ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR SEQRES 26 A 331 LEU ILE PRO GLN GLN GLY SEQRES 1 B 331 GLY SER PRO SER GLY GLU ALA PRO ASN GLN ALA LEU LEU SEQRES 2 B 331 ARG ILE LEU LYS GLU THR GLU PHE LYS LYS ILE LYS VAL SEQRES 3 B 331 LEU GLY SER GLY ALA PHE GLY THR VAL TYR LYS GLY LEU SEQRES 4 B 331 TRP ILE PRO GLU GLY GLU LYS VAL LYS ILE PRO VAL ALA SEQRES 5 B 331 ILE LYS GLU LEU ARG GLU ALA THR SER PRO LYS ALA ASN SEQRES 6 B 331 LYS GLU ILE LEU ASP GLU ALA TYR VAL MET ALA SER VAL SEQRES 7 B 331 ASP ASN PRO HIS VAL CYS ARG LEU LEU GLY ILE CYS LEU SEQRES 8 B 331 THR SER THR VAL GLN LEU ILE MET GLN LEU MET PRO PHE SEQRES 9 B 331 GLY CYS LEU LEU ASP TYR VAL ARG GLU HIS LYS ASP ASN SEQRES 10 B 331 ILE GLY SER GLN TYR LEU LEU ASN TRP CYS VAL GLN ILE SEQRES 11 B 331 ALA LYS GLY MET ASN TYR LEU GLU ASP ARG ARG LEU VAL SEQRES 12 B 331 HIS ARG ASP LEU ALA ALA ARG ASN VAL LEU VAL LYS THR SEQRES 13 B 331 PRO GLN HIS VAL LYS ILE THR ASP PHE GLY LEU ALA LYS SEQRES 14 B 331 LEU LEU GLY ALA GLU GLU LYS GLU TYR HIS ALA GLU GLY SEQRES 15 B 331 GLY LYS VAL PRO ILE LYS TRP MET ALA LEU GLU SER ILE SEQRES 16 B 331 LEU HIS ARG ILE TYR THR HIS GLN SER ASP VAL TRP SER SEQRES 17 B 331 TYR GLY VAL THR VAL TRP GLU LEU MET THR PHE GLY SER SEQRES 18 B 331 LYS PRO TYR ASP GLY ILE PRO ALA SER GLU ILE SER SER SEQRES 19 B 331 ILE LEU GLU LYS GLY GLU ARG LEU PRO GLN PRO PRO ILE SEQRES 20 B 331 CYS THR ILE ASP VAL TYR MET ILE MET VAL LYS CYS TRP SEQRES 21 B 331 MET ILE ASP ALA ASP SER ARG PRO LYS PHE ARG GLU LEU SEQRES 22 B 331 ILE ILE GLU PHE SER LYS MET ALA ARG ASP PRO GLN ARG SEQRES 23 B 331 TYR LEU VAL ILE GLN GLY ASP GLU ARG MET HIS LEU PRO SEQRES 24 B 331 SER PRO THR ASP SER ASN PHE TYR ARG ALA LEU MET ASP SEQRES 25 B 331 GLU GLU ASP MET ASP ASP VAL VAL ASP ALA ASP GLU TYR SEQRES 26 B 331 LEU ILE PRO GLN GLN GLY HET 3LH A1101 32 HET CL B1101 1 HETNAM 3LH N-{2-METHYL-5-[2-OXO-9-(1H-PYRAZOL-4-YL)BENZO[H][1, HETNAM 2 3LH 6]NAPHTHYRIDIN-1(2H)-YL]PHENYL}PROPANAMIDE HETNAM CL CHLORIDE ION FORMUL 3 3LH C25 H21 N5 O2 FORMUL 4 CL CL 1- FORMUL 5 HOH *22(H2 O) HELIX 1 AA1 LYS A 708 THR A 710 5 3 HELIX 2 AA2 SER A 752 VAL A 769 1 18 HELIX 3 AA3 LEU A 798 LYS A 806 1 9 HELIX 4 AA4 GLY A 810 ARG A 831 1 22 HELIX 5 AA5 ALA A 839 ARG A 841 5 3 HELIX 6 AA6 ALA A 882 ARG A 889 1 8 HELIX 7 AA7 THR A 892 THR A 909 1 18 HELIX 8 AA8 PRO A 919 GLY A 930 1 12 HELIX 9 AA9 THR A 940 TRP A 951 1 12 HELIX 10 AB1 LYS A 960 ASP A 974 1 15 HELIX 11 AB2 ASP A 974 LEU A 979 1 6 HELIX 12 AB3 ALA A 1013 ILE A 1018 1 6 HELIX 13 AB4 LYS B 708 THR B 710 5 3 HELIX 14 AB5 SER B 752 VAL B 769 1 18 HELIX 15 AB6 CYS B 797 HIS B 805 1 9 HELIX 16 AB7 GLY B 810 ARG B 832 1 23 HELIX 17 AB8 ALA B 882 ARG B 889 1 8 HELIX 18 AB9 THR B 892 THR B 909 1 18 HELIX 19 AC1 PRO B 919 GLY B 930 1 12 HELIX 20 AC2 THR B 940 TRP B 951 1 12 HELIX 21 AC3 LYS B 960 ASP B 974 1 15 HELIX 22 AC4 ASP B 974 LEU B 979 1 6 HELIX 23 AC5 SER B 995 MET B 1002 1 8 SHEET 1 AA1 5 PHE A 712 SER A 720 0 SHEET 2 AA1 5 GLY A 724 TRP A 731 -1 O LYS A 728 N LYS A 716 SHEET 3 AA1 5 ILE A 740 LEU A 747 -1 O GLU A 746 N THR A 725 SHEET 4 AA1 5 GLN A 787 GLN A 791 -1 O MET A 790 N ALA A 743 SHEET 5 AA1 5 LEU A 777 CYS A 781 -1 N GLY A 779 O ILE A 789 SHEET 1 AA2 3 GLY A 796 CYS A 797 0 SHEET 2 AA2 3 VAL A 843 VAL A 845 -1 O VAL A 845 N GLY A 796 SHEET 3 AA2 3 VAL A 851 ILE A 853 -1 O LYS A 852 N LEU A 844 SHEET 1 AA3 2 LEU A 833 VAL A 834 0 SHEET 2 AA3 2 LYS A 860 LEU A 861 -1 O LYS A 860 N VAL A 834 SHEET 1 AA4 2 TYR A 869 HIS A 870 0 SHEET 2 AA4 2 ILE A 890 TYR A 891 -1 O TYR A 891 N TYR A 869 SHEET 1 AA5 5 PHE B 712 SER B 720 0 SHEET 2 AA5 5 THR B 725 TRP B 731 -1 O VAL B 726 N GLY B 719 SHEET 3 AA5 5 ILE B 740 GLU B 746 -1 O ILE B 740 N TRP B 731 SHEET 4 AA5 5 GLN B 787 GLN B 791 -1 O LEU B 788 N LYS B 745 SHEET 5 AA5 5 LEU B 777 CYS B 781 -1 N GLY B 779 O ILE B 789 SHEET 1 AA6 2 LEU B 833 HIS B 835 0 SHEET 2 AA6 2 LEU B 858 LYS B 860 -1 O ALA B 859 N VAL B 834 SHEET 1 AA7 2 VAL B 843 THR B 847 0 SHEET 2 AA7 2 HIS B 850 ILE B 853 -1 O HIS B 850 N THR B 847 LINK SG CYS A 797 CAR 3LH A1101 1555 1555 1.81 SITE 1 AC1 8 LEU A 718 VAL A 726 LEU A 792 MET A 793 SITE 2 AC1 8 PRO A 794 CYS A 797 LEU A 799 ASP A 800 SITE 1 AC2 3 VAL B 876 PRO B 877 ILE B 878 CRYST1 47.575 93.288 163.860 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021019 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010719 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006103 0.00000